ENDOMETRIAL HYPOPLASIA

ENDOMETRIAL HYPOPLASIA was reported 24 times

ENDOMETRIAL HYPOPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Gonadotropin [EPC] 1 0.0005
1 Progesterone [EPC] 1 0.0000
2 Progestin [EPC] 6 0.0000
3 Copper-containing Intrauterine Device [EPC] 1 0.0000
4 Methylxanthine [EPC] 1 0.0000
5 Central Nervous System Stimulant [EPC] 1 0.0000
6 Estrogen [EPC] 2 0.0000
7 Aromatase Inhibitor [EPC] 1 0.0000
8 Vitamin D [EPC] 2 0.0000
9 Retinoid [EPC] 1 0.0000
10 Vitamin B12 [EPC] 1 0.0000
11 Vitamin C [EPC] 1 0.0000
12 Atypical Antipsychotic [EPC] 1 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
14 Platelet Aggregation Inhibitor [EPC] 1 0.0000
15 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
16 Benzodiazepine [EPC] 1 0.0000